Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chadwick, D.
Right arrow Articles by Privitera, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chadwick, D.
Right arrow Articles by Privitera, M.
Related Collections
Right arrow All Clinical trials
Right arrow All Neuropsychology/Behavior
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs
Right arrowRelated Article
Neurology, Vol. 67, Issue 3, 378-379, August 8, 2006

EDITORIALS

How skeptical should we be about industry-sponsored studies?

David Chadwick and Michael Privitera

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:


Related Article

Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy
D. Blum, K. Meador, V. Biton, T. Fakhoury, B. Shneker, S. Chung, K. Mills, A. Hammer, and J. Isojärvi
Neurology 2006 67: 400-406. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 NeurologyHome page
K. J. Meador and D. Chadwick
How skeptical should we be about industry-sponsored studies?
Neurology, April 10, 2007; 68(15): 1238 - 1238.
[Full Text] [PDF]

Home page
 StrokeHome page
M. I. Weintraub
Response to Letters by Whiteley et al and Goldstein et al
Stroke, November 1, 2006; 37(11): 2664 - 2665.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

How skeptical should we be about industry-sponsored studies?
Kimford J. Meador
Neurology Online, 4 Dec 2006 [Full text]
Reply from the Author
David Chadwick
Neurology Online, 4 Dec 2006 [Full text]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chadwick, D.
Right arrow Articles by Privitera, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chadwick, D.
Right arrow Articles by Privitera, M.
Related Collections
Right arrow All Clinical trials
Right arrow All Neuropsychology/Behavior
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs
Right arrowRelated Article